LEXX - Lexaria Bioscience Corp. Quarterly EPS earnings growth
Lexaria Bioscience (LEXX) relies on outsourced production via CMOs, which makes the business dependent on vendors. The quarterly EPS growth vector on the GURU.Markets chart shows that the indicator has reached the level of 60.70. Passive income is generated by royalties from the licensing of delivery systems, while the development of DehydraTECH technology improves drug absorption for diabetes and hypertension.
%20Earnings%20per%20share%20growth%20in%20annualized%20terms%20for%20the%20last%20twelve%20months&width=1200&height=400&colorIndex=0&v=mwa76aez.ocr-7cpmfb4&start=20220704&end=20261110&filename=GURU_Markets_-_LEXX_-_Lexaria-Bioscience_-_Earnings-per-share-growth-in-annualized-terms-for-the-last-twelve-months "Lexaria Bioscience Corp. (LEXX): Year-over-year earnings per share growth for the last twelve months from 07/04/2022 to 11/10/2026 | 👁️GURU.Markets👁️")
Analytical breakdowns for Lexaria Bioscience
- share price and expert price forecast:
- market capitalization statistics:
- balance sheet net asset value indicators:
- company liabilities and liquidity data:
Total Debt to Capital Lexaria Bioscience|LEXX - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio lexariabioscience.com|LEXX - Company Aggregate Debt|Debts to Book Capitalization Lexaria|LEXX - Company Long-Term Debts|Company Short-Term Debt Lexaria Bioscience|Quick Ratio lexariabioscience.com
- earnings and market multiples details:
LEXX - Net Financial Result|Projected Future Earnings Lexaria Bioscience|LEXX - P/E Multiple|Projected Price to Earnings lexariabioscience.com|LEXX - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Lexaria|LEXX - Profit before payment of interest, taxes and amortization|Net earnings per share (EPS TTM) Lexaria Bioscience|LEXX - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months lexariabioscience.com|LEXX - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Lexaria Bioscience
Summary company analysis:Lexaria Bioscience Corp - LEXX
The DehydraTECH licensing model provides Lexaria Bioscience (LEXX) with a steady stream of royalties without manufacturing costs, which directly determines net income dynamics. By analyzing the quarterly EPS gap, investors assess the growth rate of earnings per share, filtering out random market noise to identify the real impact of inflationary costs on margins and the company's ultimate capital stability.
Competitor analysis
HLN: Quarterly EPS earnings growth|Kenvue Inc - Year-over-year earnings per one share growth for the last 12 months|VRNA (Verona Pharma Corp) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Jyong Bio MENS|Year-over-year earnings per share growth for the last twelve months Ligand Pharmaceuticals (LGND)|AMRX (amneal.com) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Perrigo PRGO|Alvotech S.A. - Year-over-year earnings per share growth for the last twelve months|Liquidia Technologies - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Galapagos Corp|ANIP (ANI Pharmaceuticals) - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per share growth for the last 12 months MNKD|AMPH (Amphastar Pharmaceuticals, Inc.) - Quarterly EPS earnings growth|Quarterly EPS earnings growth Pacira Pharmaceuticals|Year-over-year earnings per share growth for the last twelve months ARS Pharma (SPRY)|TBPH (Theravance Corp) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth AQST (Aquestive Therapeutics)|Year-over-year net earnings per share change for the last twelve months scPharmaceuticals, Inc. (SCPH)|Tectonic - Quarterly EPS earnings growth|TNXP - Quarterly EPS earnings growth|SXTC (sxtchina.com) - Year-over-year net earnings per share growth for the last 12 months|Eupraxia Pharmaceuticals Inc. - Year-over-year earnings per one share growth for the last 12 months|BHST (BioHarvest Sciences) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months EXOZ|Quarterly EPS earnings growth ORMP|Year-over-year net earnings per share change for the last twelve months enterabio.com|Year-over-year earnings per share growth for the last twelve months MindWalk HYFT|ABVC BioPharma, Inc (ABVC) - Earnings per share growth in annualized terms for the last twelve months|CPIX - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months quantumbiopharma.com QNTM|FGEN: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Telomir Pharmaceuticals Inc|RANI (Rani Therapeutics Holdings) - Quarterly EPS earnings growth|Synergy CHC Corporation (SNYR) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth RLYB|PULM - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months Pheton Holdings PTHL|APM: Year-over-year earnings per share growth for the last 12 months|Lyra Therapeutics, Inc - Quarterly EPS earnings growth|impactbiomedinc.com (IBO) - Year-over-year net earnings per share growth for the last 12 months|TNFA: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months cbdMD (YCBD)|Year-over-year earnings per share growth for the last twelve months PainReform|Year-over-year earnings per share growth for the last twelve months CYTO|Quarterly EPS earnings growth LIPO|OPTN - Earnings per share growth in annualized terms for the last twelve months|Pieris Pharmaceuticals - Year-over-year net earnings per share growth for the last 12 months|PROC: Year-over-year earnings per share growth for the last 12 months|PTPI: Year-over-year net earnings per share growth for the last 12 months|QLI (Qilian International Holding Group) - Year-over-year earnings per share growth for the last 12 months|ACELYRIN, Inc. (SLRN) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months TFFP (TFF Pharmaceuticals, Inc)
